Enveric Biosciences, Inc. - Common Stock, $0.01 par value (ENVB)

CUSIP: 29405E208

Q1 2023 13F Holders as of 31 Mar 2023

Holder snapshot 6 signals
Share change
+54,958
SEC-reported price per share
$1.68
Indexed holders
12
Value change
+$92,449
Number of buys
6
Number of sells
2
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
1,022,530

Security key

29405E208

Report period

Q1 2023

Indexed institutions

12

Top holders

8

Ownership snapshot

Top reported holders of ENVB - Enveric Biosciences, Inc. - Common Stock, $0.01 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
AdvisorShares Investments...
Disclosed value leader
AdvisorShares Investments...
Comparable rows
0/14
Latest evidence
25 Jan 2023
13F 3/4/5 Highest disclosed value: $238,405 14 rows are not safely comparable across share classes. Showing 1-6 of 14 holder rows.

Quick read

AdvisorShares Investments LLC has the largest disclosed position value at $238.4K.

0 of 14 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens AdvisorShares Investments LLC's linked filing trail.
Disclosed position value Top 5
AdvisorShares Investments LLC $238.4K
BlackRock Finance, Inc. $61.5K
VANGUARD GROUP INC $30K
Tower Research Capital LLC (TRC) $21K
UBS Group AG $5K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 14 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
AdvisorShares Investments LLC
13F
Company
13F
—
denominator unverified
$238,405
116,295 shares
— 31 Dec 2022
BlackRock Finance, Inc.
13F
Company
13F
—
denominator unverified
$61,522
29,578 shares
— 31 Dec 2022
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$30,004
14,425 shares
— 31 Dec 2022
Tower Research Capital LLC (TRC)
13F
Company
13F
—
denominator unverified
$21,000
9,817 shares
— 31 Dec 2022
UBS Group AG
13F
Company
13F
—
denominator unverified
$5,005
2,406 shares
— 31 Dec 2022
GROUP ONE TRADING LLC
13F
Company
13F
—
denominator unverified
$560
273 shares
— 31 Dec 2022
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Indexed institutions
12
Shares
227,883
Indexed holders
12
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Reported share positions only; options and principal amounts are excluded. Missing manager disclosures are unavailable, not zero. A missing position becomes zero only when complete coverage is verified for both snapshots. Counts describe the indexed universe; the comparison may cover a smaller set.

Compare Q1 2023 vs Q4 2022 Across Filers

Q4 2022 indexed holders
10
Q1 2023 indexed holders
12
Indexed holder difference
2
Investor Q4 2022 Shares Q1 2023 Shares Share Diff Share Chg % Q4 2022 value Q1 2023 value Value change Value Chg %

Trend: the last eight indexed quarters, including the selected comparison periods.

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .